Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

NCT04169399 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Toripalimab
RADIATION: Stereotactic body radiotherapy

Sponsor

Sun Yat-sen University